Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/1995
03/14/1995CA2131755A1 Nucleic acid-binding oligomers possessing n-branching for therapy and diagnostics
03/14/1995CA2106015A1 Ribozymes having 2'-0 substituted nucleotides in the flanking sequences
03/14/1995CA1334761C Benzylamine derivatives, process for production thereof, and use thereof
03/14/1995CA1334759C N,n'-diaminocarbonylmethyl-n,n'-dicarboxymethyl-1,2- diaminoethane derivatives
03/14/1995CA1334756C 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
03/09/1995WO1995006732A2 Bacterial exported proteins and acellular vaccines based thereon
03/09/1995WO1995006410A1 Treatment of chronic inflammatory diseases by angiotension ii receptor antagonists
03/09/1995WO1995001348A3 Imides as inhibitors of tnp alpha
03/09/1995CA2170726A1 Bacterial exported proteins and acellular vaccines based thereon
03/09/1995CA2131512A1 Nutritional supplement
03/08/1995EP0641797A1 Cephem derivatives and antimicrobial agents containing the same
03/08/1995EP0641795A1 Carbapenem derivative
03/08/1995EP0641793A1 5-Amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
03/08/1995EP0641562A1 Nutritional supplement
03/08/1995EP0641359A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
03/08/1995EP0641357A1 Hiv protein epitopes immunologically homologous to hla
03/08/1995EP0641344A1 8-substituted anthines as phosphodiesterase inhibitors
03/08/1995EP0641341A1 METHOD FOR PREPARING BENZO b]NAPHTHYRIDINES
03/08/1995EP0641339A1 Azaspiro quinolone antibacterial agents
03/08/1995EP0641325A1 Retroviral protease inhibitors
03/08/1995EP0641324A1 Tetrahydro and perhydro isoquinolin derivatives and therapeutic agents containing them
03/08/1995EP0641319A1 N- N'-(5-AMINO-4-HYDROXY-ACYLOYL)-$g(a)-AMINOACYLOYL] SUBSTITUTED HETEROCYCLES AND THEIR USE AS ANTIVIRAL AGENTS
03/08/1995EP0641306A1 Carbocyclic and heterocyclic hiv protease inhibitors
03/08/1995EP0641212A1 Method and reagent for inhibiting cancer development
03/08/1995EP0641207A1 Enantiomeric cynemicin analogs, preparation and use thereof
03/08/1995EP0484382B1 Feline calicivirus capsid protein and nucleotide sequence
03/08/1995EP0427843B1 Specific inhibitor for retrovirus reverse transcriptase, and its application as a medicament
03/08/1995CN1099798A Hepatitis a virus vaccine
03/08/1995CN1099750A 4-oxo-azetidin-2-sulfonic-acid-amide and salt of same, preparation and application of same
03/08/1995CN1099644A Wenxianglu smell medicinal liquid for curing cold
03/07/1995US5395944 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)quinolonecarboxylic and 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)naphthyridone-carboxylic acid intermediates
03/07/1995US5395614 Vaccines reducing severity of blood-stage malaria
03/07/1995CA1334655C De-mannosyl teicoplanin derivatives
03/02/1995WO1995006250A1 Molecular clones producing recombinant dna antigens of the hards virus
03/02/1995WO1995006119A1 Recombinant humanized anti-human immunodeficiency virus antibody
03/02/1995WO1995006055A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
03/02/1995WO1995006054A1 Compound uch9
03/02/1995WO1995006047A1 Antimicrobial quinolinyl-(1h-1,2,4-triazol-1-yl)alkanol derivatives
03/02/1995WO1995006034A1 Compounds and methods for inhibition of hiv and related viruses
03/02/1995WO1995005852A1 Agent against sensitive, hyperreactive and hypoactive states of the skin, forms of acne, atopic dermatitides, psoriasis, prurigo, photodermatoses, ichthyosis and viral infections
03/02/1995WO1995005850A1 Campylobacter jejuni antigens, and methods for their production and use
03/02/1995WO1995005847A1 Accessory factor function for interferon gamma and its receptor
03/02/1995WO1995005844A1 Method for the prevention and treatment of bovine mastitis
03/02/1995WO1995005817A1 Novel 1,2-dithiin antiinfective agents
03/02/1995WO1995003414A3 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
03/02/1995WO1994028726A3 Method of treating retained pulmonary secretions
03/02/1995WO1994025601A3 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/02/1995DE4407859C1 Vector for liver-specific gene therapy
03/02/1995CA2623540A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
03/02/1995CA2170140A1 Novel 1,2-dithiin antiinfective agents
03/02/1995CA2170031A1 Antimicrobial quinolinyl-(1h-1,2,4-triazol-1-yl)alkanol derivatives
03/02/1995CA2169849A1 Accessory factor function for interferon gamma and its receptor
03/02/1995CA2169748A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
03/02/1995CA2168030A1 Molecular clones producing recombinant dna antigens of the hards virus
03/02/1995CA2167691A1 Campylobacter jejuni antigens, and methods for their production and use
03/02/1995CA2147612A1 Compound uch9
03/01/1995EP0640688A1 Ribozymes
03/01/1995EP0640614A2 Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates
03/01/1995EP0640607A1 2-Beta-alkenyl-penem-sulfonyl compounds as beta-lacterase inhibitors
03/01/1995EP0640349A1 Vaccinal efficacy augmentor and efficacy-augmenting foods
03/01/1995EP0640348A1 Oil-based and water-based adjuvant mixture
03/01/1995EP0640346A1 Uses of sulphated sugars against inflammation
03/01/1995EP0640345A2 Composition for inhibiting transmission of AIDS, containing silver salts with a detergent
03/01/1995EP0640128A1 Attenuated respiratory syncytial virus vaccine compositions
03/01/1995EP0640098A1 Canine coronavirus s gene and uses therefor
03/01/1995EP0640097A1 Compositions and methods for vaccination against coronaviruses
03/01/1995EP0640096A1 Universal coronavirus vaccine
03/01/1995EP0640095A1 Process for making vancomycin
03/01/1995EP0640088A1 Novel tricyclic thiazolo and thiazino derivatives and anti-viral medicaments containing them.
03/01/1995EP0640087A1 Use of tricyclic pyrimidine derivatives as anti-viral medicaments
03/01/1995EP0640077A1 Oxazolidinones containing a substituted diazine moiety and their use as antimicrobials
03/01/1995EP0640074A1 Novel salts of a quinolone-carboxylic acid
03/01/1995EP0639983A1 Antiviral agent comprising cd4 and an h2 histone
03/01/1995EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
03/01/1995EP0639977A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
03/01/1995EP0520011B1 Vaccines for preventing furunculosis in fish
03/01/1995EP0486609B1 Pharmaceutical product for the treatment of sepsis
03/01/1995CA2131224A1 Treating water for dermatoses in domestic animals
02/1995
02/28/1995US5393883 Ribonucleotide reductase inhibitors
02/28/1995US5393878 Pyrimidine nucleosides having cyclopentafuran skeleton
02/28/1995US5393792 High dosage topical forms of collagenase
02/28/1995US5393758 Substituted azetidinylpyridone naphthyridine carboxylic acid derivatives and their application as medical products
02/28/1995US5393751 Antibiotics
02/28/1995US5393743 Erythromycin derivatives
02/28/1995US5392725 Sewing machine needle and method for manufacturing same
02/28/1995CA2028560C Methods and compositions employing certain lysozymes and endoglycosidases
02/28/1995CA1334577C Method of preventing pneumocystis carinii pneumonia using pentamidine in an aerosol form
02/28/1995CA1334576C Antiviral pharmaceutical compositions and process for preparing same
02/28/1995CA1334573C Aqueous antimicrobial ophthalmic solutions
02/26/1995CA2130612A1 Vaccinal efficacy augmentor and efficacy-augmenting foods
02/24/1995CA2130230A1 Sugar-modified interferon
02/23/1995WO1995005467A2 Chitinase, dna coding therefor and plants containing same
02/23/1995WO1995005393A2 Lipopolysaccharide-binding and neutralizing peptides
02/23/1995WO1995005378A1 Antiviral thiazoles
02/23/1995WO1995005373A1 Novel quinolone carboxylic acid derivatives
02/23/1995WO1995005363A1 Amidine derivatives with nitric oxide synthetase activities
02/23/1995WO1995005194A1 Vaccine compositions
02/23/1995WO1995005180A1 Methods and compositions for inhibiting uridine secretion
02/23/1995WO1995005171A1 Anti-mrsa composition
02/23/1995DE4407538C1 Binding reagent for cell surface protein and effector cell
1 ... 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 ... 1798